An increased neutrophil–lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation

[1]  M. Lynch.  The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease , 2014, Immunology.

[2]  Nick C Fox,et al.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.

[3]  E. Siemers,et al.  Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.

[4]  Blaine R. Roberts,et al.  Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease , 2014, Alzheimer's & Dementia.

[5]  C. Rowe,et al.  Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. , 2014, Journal of Alzheimer's disease : JAD.

[6]  D. Butterfield,et al.  Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease. , 2013, Free radical biology & medicine.

[7]  T. Atsumi,et al.  Regulation of Immune Cell Infiltration into the CNS by Regional Neural Inputs Explained by the Gate Theory , 2013, Mediators of inflammation.

[8]  M. Guillot-Sestier,et al.  Innate immunity in Alzheimer's disease: a complex affair. , 2013, CNS & neurological disorders drug targets.

[9]  G. Cappellano,et al.  Immunity and inflammation in neurodegenerative diseases. , 2013, American journal of neurodegenerative disease.

[10]  B. Popescu,et al.  Is There a Causal Link between Inflammation and Dementia? , 2013, BioMed research international.

[11]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[12]  C. Rowe,et al.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.

[13]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[14]  T. Costantino,et al.  Neutrophil to lymphocyte ratio and cardiovascular diseases: a€review , 2012 .

[15]  Justin Bedo,et al.  Blood-based protein biomarkers for diagnosis of Alzheimer disease. , 2012, Archives of neurology.

[16]  Z. A. Oztürk,et al.  The Evaluation of Neutrophil-Lymphocyte Ratio in Alzheimer’s Disease , 2012, Dementia and Geriatric Cognitive Disorders.

[17]  D. Prvulovic,et al.  Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes , 2012, Molecular Neurobiology.

[18]  Olivier Salvado,et al.  Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. , 2012, Brain : a journal of neurology.

[19]  K. Peter,et al.  Amyloid Plaques Dissociate Pentameric to Monomeric C‐Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease? , 2012, Brain pathology.

[20]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[21]  M. Sastre,et al.  Microglia Function in Alzheimer’s Disease , 2012, Front. Pharmacol..

[22]  S. Mirza,et al.  Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population , 2012, International archives of medicine.

[23]  K. Blennow,et al.  Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study. , 2012, Journal of Alzheimer's disease : JAD.

[24]  Clifford R Jack,et al.  Testing the Right Target and Right Drug at the Right Stage , 2011, Science Translational Medicine.

[25]  Lee T. Sam,et al.  Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study , 2011, Science Translational Medicine.

[26]  P. Järemo,et al.  Alzheimer’s disease is characterized by more low‐density erythrocytes with increased volume and enhanced β‐amyloid x‐40 content , 2011, Journal of internal medicine.

[27]  C. Rowe,et al.  Amyloid-β: the seeds of darkness. , 2011, The international journal of biochemistry & cell biology.

[28]  D. Selkoe,et al.  Resolving controversies on the path to Alzheimer's therapeutics , 2011, Nature Medicine.

[29]  C. Jack,et al.  Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI , 2011, Acta Neuropathologica.

[30]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[31]  M. Ferretti,et al.  Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment? , 2011, Current Alzheimer research.

[32]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Alzheimer's Disease , 2010, Biological Psychiatry.

[33]  S. Nam,et al.  Inflammation and Alzheimer’s disease , 2010, Archives of pharmacal research.

[34]  C. Hunter,et al.  Trafficking of immune cells in the central nervous system. , 2010, The Journal of clinical investigation.

[35]  C. Hong,et al.  Peripheral Cytokines and Chemokines in Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.

[36]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[37]  A. Nicholson,et al.  Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.

[38]  P. Mcgeer,et al.  Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. , 2008, Journal of Alzheimer's disease : JAD.

[39]  B. McColl,et al.  Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms , 2007, The Journal of Neuroscience.

[40]  M. ChB.,et al.  Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer , 2005, Journal of surgical oncology.

[41]  J. Ringman,et al.  Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. , 2005, Journal of Alzheimer's disease : JAD.

[42]  F. LaFerla,et al.  Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau , 2004 .

[43]  B. Michel,et al.  Oxidative Stress Level in Circulating Neutrophils Is Linked to Neurodegenerative Diseases , 2004, Journal of Clinical Immunology.

[44]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[45]  N. Voskresenskaya,et al.  Phagocytic Activity and State of Bactericidal Systems in Polymorphonuclear Leukocytes from Patients with Alzheimer's Disease , 2003, Bulletin of Experimental Biology and Medicine.

[46]  S. Sorbi,et al.  Neutrophils CD11b and fibroblasts PGE2 are elevated in Alzheimer’s disease , 2002, Neurobiology of Aging.

[47]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[48]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[49]  H. Anisman,et al.  Alterations in immune functions during normal aging and Alzheimer's disease , 1999, Psychiatry Research.

[50]  J. Thyberg,et al.  Human neutrophil phagocytic granules contain a truncated soluble form of the Alzheimer beta/A4 amyloid precursor protein (APP). , 1994, The Journal of biological chemistry.

[51]  T. Fulop,et al.  Altered post-receptorial signal transduction mechanism under various stimulation in polymorphonuclear granulocytes of Alzheimer's disease , 1990, Mechanisms of Ageing and Development.

[52]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.